← Leaderboards
Nickolas Papadopoulos
Johns Hopkins University
$5,896,866
Attributed
$9,469,844
Total exposure
4
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.7M · FY2018–25$2M$1.5M$1M$500K$0
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$9,469,844 · 4
By mechanism
U01$5,788,296 · 1
P50$3,027,729 · 2
R01$653,819 · 1
Top collaborators
- Chetan Bettegowda8 shared
- Nishant Agrawal3 shared
- Alison P Klein1 shared
Most similar at Johns Hopkins University
Same institution · by research overlap
- Anirban Maitra$50,247,714
- Ie-Ming Shih$14,895,140
- Elizabeth Harper$316,514
- Francis M Giardiello$6,524,423
- Zhen Zhang$10,302,020
Others in their field
Other Emerging Leaders on “Malignant Neoplasms”
- Leonard Freedman · Leidos Biomedical Research, Inc.$527,106,485
- Ethan Dmitrovsky · Leidos Biomedical Research, Inc.$357,875,933
- Lynn Briscoe · Leidos Biomedical Research, Inc.$186,892,879
- Leonard Freedmand · Leidos Biomedical Research, Inc.$108,968,336
- Beverly Hayes · Leidos Biomedical Research, Inc.$98,336,166
- Martha Hering · Westat, Inc.$57,098,843
Research focus
Malignant NeoplasmsSpecificityDetectionAneuploidyPerformanceMutationDiagnosisTumorScreening For CancerBloodCohortEarly DiagnosisMortalityMedicalSensitivity And SpecificityPlasmaInnovationCancer CellSamplingTumor DnaLiquid BiopsyLiquid SubstanceTissuesLesion
Grant awards (16)
Multi-analyte Approach for Earlier Detection of Cancers in Non Plasma Biofluids$708,799
U01 · FY2025 · CA · contact PI
Improving Management of patients at High Risk of Pancreatic Cancer$653,819
R01 · FY2025 · CA
Project 1: Diagnose high-grade ovarian serous carcinoma precursors and occult tumors$300,358
P50 · FY2025 · CA · contact PI
Project 1: Diagnose high-grade ovarian serous carcinoma precursors and occult tumors$650,015
P50 · FY2024 · CA · contact PI
Multi-analyte Approach for Earlier Detection of Cancers in Non Plasma Biofluids$415,618
U01 · FY2024 · CA · contact PI
Multi-analyte Approach for Earlier Detection of Cancers in Non Plasma Biofluids$987,109
U01 · FY2023 · CA · contact PI
Earlier Detection of Cancers using Non-Plasma Based Liquid Biopsies$721,220
U01 · FY2022 · CA · contact PI
"Applying PapGene test for early ovarian cancer detection"$422,596
P50 · FY2022 · CA · contact PI
Earlier Detection of Cancers using Non-Plasma Based Liquid Biopsies$736,145
U01 · FY2021 · CA · contact PI
"Applying PapGene test for early ovarian cancer detection"$256,093
P50 · FY2021 · CA · contact PI
Earlier Detection of Cancers using Non-Plasma Based Liquid Biopsies$736,346
U01 · FY2020 · CA · contact PI
"Applying PapGene test for early ovarian cancer detection"$428,569
P50 · FY2020 · CA · contact PI
Earlier Detection of Cancers using Non-Plasma Based Liquid Biopsies$714,445
U01 · FY2019 · CA · contact PI
"Applying PapGene test for early ovarian cancer detection"$468,282
P50 · FY2019 · CA · contact PI
Earlier Detection of Cancers using Non-Plasma Based Liquid Biopsies$768,614
U01 · FY2018 · CA · contact PI
"Applying PapGene test for early ovarian cancer detection"$501,816
P50 · FY2018 · CA · contact PI